Continental Breakfast

7:30 am – 8:00 am
Refreshments and Networking in the Exhibit Hall

Welcome

8:00 am - 8:05 am
Opening Remarks

Hematologic Malignancies: What You Need to Know in the New Wave of Immunotherapy

Moderator: David L. Porter, MD

Chronic Lymphocytic Leukemia and Acute Lymphocytic Leukemia

8:05 am – 8:08 am
Pretest
8:09 am – 8:27 am
Targeted Therapies in the Treatment of Chronic Lymphocytic Leukemia
Anthony R. Mato, MD
8:28 am – 8:46 am
Chimeric Antigen Receptor T cells in the Treatment of Chronic Lymphocytic Leukemia
David L. Porter, MD
8:47 am – 9:05 am
Targeted Therapies in the Treatment of Acute Lymphocytic Leukemia
Anjali S. Advani, MD
9:06 am – 9:24 am
Chimeric Antigen Receptor T cells in the Treatment of Acute Lymphocytic Leukemia
Shannon L. Maude, MD, PhD
9:25 am – 9:30 am
Discussion and Posttest
9:30 am – 10:00 am
Refreshments and Networking in the Exhibit Hall

Emerging Challenges and New Data on Immunotherapies: The Great Debate

Moderators: Sanjiv S. Agarwala, MD; Edward S. Kim, MD; David L. Porter, MD
10:00 am – 10:05 am
Pretest
10:06 am – 10:26 am
Mini Debate: Are Chimeric Antigen Receptor T cells Worth the Cost? Pro: Speaker To Be Announced Con: Speaker To Be Announced
10:27 am – 10:32 am
Discussion
10:33 am – 10:53 am
Mini Debate: Head and Neck Cancer
Pro: Robert L. Ferris, MD, PhD
Con: Nabil F. Saba, MD, FACP
10:54 am – 10:59 am
Discussion
11:00 am – 11:20 am
Mini Debate: Should All Patients with Lung Cancer Receive Immunotherapy Before Chemotherapy?
Pro: Young Kwang Chae, MD, MPH, MBA
Con: Shirish M. Gadgeel, MD
11:21 am – 11:26 am
Discussion
11:27 am – 11:47 am
Mini Debate: Can Chimeric Antigen Receptor T cells Replace Blood Marrow Transplants?
Pro: Anjali Advani, MD
Con: Shannon Maude, MD, PhD
11:48 am – 12:00 pm
Discussion and Posttest

Lunch Break

12:00 pm – 1:00 pm
Lunch On Own

Hematologic Malignancies: What You Need to Know in the New Wave of Immunotherapy Part II

Moderator: David L. Porter, MD

Multiple Myeloma

1:00 pm – 1:05 pm
Pretest
1:06 pm – 1:31 pm
Targeted Therapies in the Treatment of Multiple Myeloma
Speaker To Be Announced
1:32 pm – 1:57 pm
Chimeric Antigen Receptor T cells in the Treatment of Multiple Myeloma
James N. Kochenderfer, MD

Non-Hodgkins Lymphoma

1:58 pm – 2:23 pm
Chimeric Antigen Receptor T cells in the Treatment of Non-Hodgkins Lymphoma
Stephen J. Schuster, MD
2:24 pm – 2:49 pm
Immune Checkpoint Inhibitors in the Treatment of Non-Hodgkins Lymphoma
Michael R. Bishop, MD
2:50 pm – 2:54 pm
Panel Discussion and Questions and Answers
2:55 pm – 3:00 pm
Posttest
3:00 pm – 3:30 pm
Refreshments and Networking in the Exhibit Hall

Looking into the Future

3:30 pm – 3:50 pm
T-cell Therapy Beyond CD19
Saar I. Gill, MD, PhD

What Will You Do on Monday Morning?

Moderators: Sanjiv S. Agarwala, MD; Edward S. Kim, MD; David L. Porter, MD
3:51 pm – 4:30 pm
Faculty and Audience Discussion